ABOUT US

OUR STORY

In 2013, the Biomaterials and Bioengineering Laboratory of the French National Institute for Health and Medical Research (Inserm UMR 1121), co-directed by our CSO, Dr. Philippe Lavalle, discovered the antimicrobial properties of the anti-inflammatory coatings we were working on. Between 2016 and 2018, we worked to develop our technology with the support of SATT Conectus .

In 2019, our CEO, Dr. Nihal Engin Vrana, together with 2 collaborators, Dr. Philippe Lavalle and Dr. Angela Mutschler created SPARTHA Medical and were then incubated at SEMIA. In 2021, SPARTHA Medical obtained CIR accreditation for research and development (R&D) after scientific and technical expertise.

End of 2021, SPARTHA Medical is laureate of the EIC Accelerator. This grant aims to help to deploy our innovation and start clinical evaluations. The project is called SPARTHACUS.

3 ans de SPARTHA Medical

OUR TEAM

nihal engin vrana founder CEO Spartha Medical Device Strasbourg Alsace Innovation startup Coatings Antimicrobial Anti-inflammatory Personalised Implants Nosocomial Infections Antibiotic substitutes peri-implantitis infected wound care hospital surgery
philippe lavalle Spartha Medical Device Strasbourg Alsace Innovation startup Coatings Antimicrobial Anti-inflammatory Personalised Implants Nosocomial Infections Antibiotic substitutes peri-implantitis infected wound care hospital surgery

Nihal Engin Vrana

CEO

Strategy \ Partnering Commercialisation

Philippe Lavalle

CSO

         Innovation / R&DCSO

InnovatioR

Scientific Advisory Board

Strategic Advisory Board

Pierre Schaff Spartha Medical Device Strasbourg Alsace Innovation startup Coatings Antimicrobial Anti-inflammatory Personalised Implants Nosocomial Infections Antibiotic substitutes peri-implantitis infected wound care hospital surgery

Prof. Pierre Schaaf

University of Strasbourg

Co-inventor \ Surface chemistry Expert

amir ghaemmaghami Spartha Medical Device Strasbourg Alsace Innovation startup Coatings Antimicrobial Anti-inflammatory Personalised Implants Nosocomial Infections Antibiotic substitutes peri-implantitis infected wound care hospital surgery

Prof. Ghaemmaghami

University of Nottingham

Clinical Immunology Expert

florent meyer Spartha Medical Device Strasbourg Alsace Innovation startup Coatings Antimicrobial Anti-inflammatory Personalised Implants Nosocomial Infections Antibiotic substitutes peri-implantitis infected wound care hospital surgery

Prof. Florent Meyer

University of Strasbourg

Periodontal Surgeon

severine sigrist team pdf presentation brief elevator speech Spartha Medical Device Strasbourg Alsace Innovation startup Coatings Antimicrobial Anti-inflammatory Personalised Implants Nosocomial Infections Antibiotic substitutes peri-implantitis infected wound care hospital surgery

Severine Sigrist

CEO Defymed

Class III Medical device developper \ Reglementation

guillaume vetter genoud team pdf presentation brief elevator speech Spartha Medical Device Strasbourg Alsace Innovation startup Coatings Antimicrobial Anti-inflammatory Personalised Implants Nosocomial Infections Antibiotic substitutes peri-implantitis infected wound care hospital surgery

Guillaume Vetter Genoud

Director of Deep Tech

SEMIA (Finance)

agnes dupret bories photo black and white team pdf presentation brief elevator speech Spartha Medical Device Strasbourg Alsace Innovation startup Coatings Antimicrobial Anti-inflammatory Personalised Implants Nosocomial Infections Antibiotic substitutes peri-implantitis infected wound care hospital surgery

Agnès Dupret-Bories

Chief Surgeon UITC

clinical trials

OUR PARTNERS

RESEARCH SUPPORTS

Unité de recherche UMR S1110

Institut de Recherche sur les Maladie Virales et Hépatiques

For more Informations : CONTACT US